News & Media
-
October 21, 2023
ESMO: Pre- and post-surgical immunotherapy improves outcomes for patients with operable lung cancer
MD Anderson Cancer Center News Release
-
April 11, 2022
AACR: Combination immunotherapy treatment effective before lung cancer surgery
MD Anderson Cancer Center News Release
-
February 18, 2021
Neoadjuvant combination immunotherapy improves outcomes for early stage non-small cell lung cancer -- Cascone T and Sepesi B.
MD Anderson Cancer Center News Release
-
Nov. 20, 2020
MD Anderson researchers present immunotherapy advances at Society for Immunotherapy of Cancer Annual Meeting. Highlights include positive clinical data from combination therapies in patients with melanoma and lung cancer - Cascone T and Sepesi B.
MD Anderson Newsroom
Give Now
Research Areas
Find out about the four types of research taking place at UT?MD Anderson.